Trailing-twelve-month (TTM) revenue is $825.34 Million with a year-over-year growth of +25.58%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $192,884,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $208,890,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $199,390,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $224,172,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $825,336,000 |
Current P/S: $3,516,934,904 market capitalization ÷ $825,336,000 TTM revenue = 4.26x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:45:06.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $224.17M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:47:25.229Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Centers For Medicare And Medicaid | $73M | $45M | $103M | $122M | $142M | $179M |
| Commercial Payors | $136M | $194M | $224M |
$825.34M
$825.34 Million
+25.58%
vs. $657.22M a year ago (TTM)
+21.93%
5 Year compound annual growth rate
1 Year
+25.58%
3 Year
+22.22%
5 Year
+21.93%
10 Year
+32.69%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $747.14M | +$155.30M | +26.24% |
| 2024 | $591.84M | +$99.16M | +20.13% |
| 2023 | $492.68M | +$81.76M | +19.90% |
| 2022 | $410.92M | +$88.10M | +27.29% |
| 2021 | $322.82M | +$57.66M | +21.74% |
| 2020 |
TTM Growth
+25.58%
3-Year CAGR
+22.22%
5-Year CAGR
+21.93%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:47:25.229Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $312M |
| $392M |
| Healthcare Institutions | $41M | $57M | $60M | $71M | $95M | $126M |
|---|
| Non-contracted Third-party Payors | $15M | $27M | $24M | $32M | $43M | $50M |
|---|
| $265.17M |
| +$50.61M |
| +23.59% |
| 2019 | $214.55M | +$67.28M | +45.68% |
| 2018 | $147.28M | +$48.15M | +48.57% |
| 2017 | $99.13M | +$35.06M | +54.72% |
| 2016 | $64.07M | +$27.93M | +77.29% |
